
PRAME, CT (Preferently Expressed Antigen of Melanoma, Melanoma Antigen Preferentiële Uitdrukking in Tumoren, MAPE, CT130, OPA Interacting Protein 4, OPA-interactief Proteïne 4, Opa-interactief Proteïne OIP4, OIP4) (Biotine)
Kwaliteit
ISO Gecertificeerd
Levering
24-48 uur
Technische Specificaties
9007-83-4
[PRAME]
23532
Human
Store product at 4 degree C if to be used immediately within two weeks. For long-term storage, aliquot to avoid repeated freezing and thawing and store at -20 degree C. Aliquots are stable at -20 degree C for 12 months after receipt. Dilute required amount only prior to immediate use. Further dilutions can be made in assay buffer. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
Recognizes human MAPE.
[PRAME; PRAME; MAPE; OIP4; CT130; OIP-4; MAPE; OIP4; OIP-4]
[PRAME]
[melanoma antigen preferentially expressed in tumors isoform a; Melanoma antigen preferentially expressed in tumors; melanoma antigen preferentially expressed in tumors; Opa-interacting protein OIP4; cancer/testis antigen 130; opa-interacting protein 4; preferentially expressed antigen of melanoma; preferentially expressed antigen in melanoma; Opa-interacting protein 4; OIP-4; Preferentially expressed antigen of melanoma]
5174641
NP_006106
NM_006115
P78395
Beschrijving
PRAME, CT (Preferently Expressed Antigen of Melanoma, Melanoma Antigen Preferentiële Uitdrukking in Tumoren, MAPE, CT130, OPA Interacting Protein 4, OPA-interac
Specificaties
Recent bekeken producten

0.22μm Syringe Filter
F1021
13mm, 50 / Pk, 500 / Cs

Erdafitinib
B2458-25
25 mg

TRPM4-IN-2
BA7024-1
1 mg

TRPM4-IN-1
HY-122605-01
5 mg

Anti-RAVV Envelope glycoprotein/GP Recombinant Antibody (SAA2752)
VK160013-01
50 µg

Recombinant BoHV-1 Envelope glycoprotein E
DRA167-01
50 µg

GelRed® Agarose LE
#41029-5G
1x 5 g

50 ml Disposable Serological Pipette
CPP00050
100/CS

